Key facts
- This page summarizes Myriam Curet's Form 4 filing for Mobia Medical, Inc. (MOBI).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2026, 18:11.
Myriam Curet - 30 Jul 2026 Form 4 Insider Report for Mobia Medical, Inc. (MOBI)
- Reporting relationship
- Director
- Issuer ticker
- MOBI
- Reported as of
- 30 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2026, 18:11:54 UTC
- Prior SEC filing
- 01 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Chase Leavitt, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Myriam Curet filed Form 4 for Mobia Medical, Inc. (MOBI) on 03 Aug 2026.
Change
- Previous filing in this sequence was filed on 01 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001632901
Primary reporting owner
Curet Myriam
- Relationship
- Director
- Address
- 2802 FLINTROCK TRACE, SUITE 226, AUSTIN
- Signature
- /s/ Chase Leavitt, Attorney-in-Fact
- Signature date
- 03 Aug 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MOBI
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +19,740
- Change %
- Price
- $0.000000*
- Shares after
- 19,740
- Date
- 30 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,740
- Exercise price
- $11.18
- Footnotes
- F1
MOBI
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +15,960
- Change %
- Price
- $0.000000*
- Shares after
- 15,960
- Date
- 30 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,960
- Exercise price
- $11.18
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date.
Footnote F2
The stock option will fully vest at the 2027 Annual Meeting, consistent with the Non-Employee Director Compensation Policy.